A Brain-Invading Parasite with Therapeutic Potential.
- Ivan Linares
- Nov 18, 2024
- 2 min read

A groundbreaking discovery has revealed that Toxoplasma gondii, a brain-invading parasite, could hold the key to treating neurological disorders such as Rett syndrome, Parkinson's disease, and depression.
One of the greatest challenges in neuropharmacology is delivering drugs precisely to specific brain regions to combat these conditions. For instance, Rett syndrome is characterized by a deficiency of the MecP2 protein in the brain. Addressing this deficiency requires an effective, non-invasive method to deliver more MecP2 protein to the brain.
Toxoplasma gondii, a unicellular parasite that reproduces exclusively in cats, is remarkably efficient at penetrating the human brain. In fact, it is estimated that up to one-third of the global population has been infected by this parasite at some point in their lives. While infections are typically asymptomatic, they may occasionally present as mild flu-like symptoms.
Researchers have harnessed the parasite's natural ability to cross the blood-brain barrier and interact with neurons. By genetically modifying the parasite's DNA, they engineered it to produce the MecP2 protein in targeted cells. This innovative approach resulted in widespread distribution of the protein in animal models and human neuronal cultures, with no apparent side effects.
These promising results, achieved in mice and human cell cultures, signal a major step forward. However, extensive research is still required to ensure long-term safety and efficacy before this technique can be tested in humans.
This novel therapeutic avenue highlights the potential to leverage nature’s mechanisms for groundbreaking medical advancements, offering hope for those affected by devastating neurological conditions.
Would you embrace living with such a parasite if it held the promise of a cure?
Reference:
Bracha S, Johnson HJ, Pranckevicius NA, et al. Engineering Toxoplasma gondii secretion systems for intracellular delivery of multiple large therapeutic proteins to neurons. Nat Microbiol. 2024;9(8):2051-2072. doi:10.1038/s41564-024-01750-6
Kommentare